UBS analyst Karl Keirstead raised the firm’s price target on Oracle (ORCL) to $380 from $360 and keeps a Buy rating on the shares. Oracle raised its FY30 revenue guidance and backlog metrics at its investor day, the analyst tells investors in a research note. UBS believes the stock can move higher as it executes on this guidance acceleration.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- Oracle’s Strong Growth Potential and Strategic Positioning Highlighted in Buy Rating
- Oracle’s Strategic Growth and AI Positioning Reinforce Buy Rating
- Oracle’s Promising Growth Trajectory: Buy Rating Backed by Ambitious Revenue Targets and Strategic AI Initiatives
- AMD price target raised to $300 from $250 at BofA
- Oracle price target raised to $400 from $367 at Barclays